MC-Gly-Gly-Phe-Boc
MC-Gly-Gly-Phe-Boc is involved in the synthesis of antibody-drug conjugates (ADCs) to Trastuzumab (HY-P9907) . MC-Gly-Gly-Phe-Boc can participate in cancer research[1].
Product Specifications
CAS Number
[1599440-14-8]
UNSPSC
12352005
Target
ADC Linker
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mc-gly-gly-phe-boc.html
Solubility
10 mM in DMSO
Smiles
O=C(C=CC1=O)N1CCCCCC(NCC(NCC(N[C@H](C(OC(C)(C)C)=O)CC2=CC=CC=C2)=O)=O)=O
Molecular Formula
C27H36N4O7
Molecular Weight
528.60
References & Citations
[1]Naito Hiroyuki, et al. Anti-human HER2 antibody drug conjugates with excellent safety and therapeutic antitumor effect: World Intellectual Property Organization, WO2015115091 A1 2015-08-06. |[2]Naito Hiroyuki, et al. Anti-human HER2 antibody drug conjugates with excellent safety and therapeutic antitumor effect: World Intellectual Property Organization, WO2015115091 A1 2015-08-06.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bsm-41670M-PE-Cy5.5 100 µL
Prostate Specific Antigen Monoclonal Antibody, PE-Cy5.5 Conjugated
Ask
View Details 
302720-FITC 200 µL
RSF1 (Remodeling and spacing Factor 1, Rsf-1, HBV pX-Associated Protein 8, Hepatitis B virus X-Associated Protein, p325 Subunit of RSF Chromatin-remodeling Complex, RSF1, HBXAP, XAP8) (FITC) discontinued
Ask
View Details 